14 - Experience and Challenges with Vancomycin Monitoring by AUC

10/3/2019

8:00 AM - 9:00 AM

Room: Walter E. Washington Convention Center, 150 AB

MOC Credit: Maximum of 1.0 hours of MOC Credit
CME Credit: Maximum of 1.0 hours of AMA PRA Category 1 Credit™
ACPE Credit: ACPE 1 knowledge-based contact hours of pharmacy CE
ACPE Number: 0221-9999-19-320-L01-P

Co-organized with the Society of Infectious Diseases Pharmacists

Learning Objectives:

At the conclusion of this session, participants will be able to:

differentiate vancomycin monitoring by trough and AUC
formulate an institution-specific strategy to monitor vancomycin therapy
evaluate the impact of optimal vancomycin therapy on patient outcomes

Presentations:

8:00 AM - 9:00 AM
36 - Experience and Challenges with Vancomycin Monitoring by AUC
William L. Musick, PharmD – Houston Methodist Hospital
8:00 AM - 9:00 AM
37 - Pediatric Experience
Jennifer Le, PharmD, MAS – University of California, San Diego

Moderator(s)

Jason Pogue, PharmD, BCPS, BCIDP

Clinical Professor
University of Michigan
Ann Arbor, Michigan

Disclosure: Accelerate Diagnostics: Consultant
Melinta Therapeutoics: Consultant
Merck and Co.: Consultant, Research Grant
Nabriva Therapeutics: Consultant
Paratek Pharmaceuticals: Consultant
Qpex: Consultant
Shionogi: Consultant
Tetraphase Pharmaceuticals: Consultant
Vincent Tam, PharmD

Professor
University of Houston
Houston, Texas

Disclosure: Nothing to disclose

Speaker(s)

Jennifer Le, PharmD, MAS

Professor of Clinical Pharmacy
University of California, San Diego
La Jolla, CA

Disclosure: Nothing to disclose
William Musick, PharmD

Infectious Diseases Clinical Specialist
Houston Methodist Hospital
Houston, TX

Disclosure: Nothing to disclose